Philip Howe to Trans-Activators
This is a "connection" page, showing publications Philip Howe has written about Trans-Activators.
Connection Strength
0.663
-
Smad3 potentiates transforming growth factor beta (TGFbeta )-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem. 2003 May 16; 278(20):18069-77.
Score: 0.186
-
Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis. J Biol Chem. 2000 Dec 08; 275(49):38363-70.
Score: 0.159
-
TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999 Mar 01; 18(5):1345-56.
Score: 0.141
-
Wnt signaling: physiology and pathology. Growth Factors. 2004 Sep; 22(3):141-50.
Score: 0.052
-
Regulation of the Wnt signaling pathway by disabled-2 (Dab2). EMBO J. 2003 Jun 16; 22(12):3084-94.
Score: 0.047
-
The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem. 2003 Jul 11; 278(28):26249-57.
Score: 0.047
-
TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol. 1997 Mar 01; 158(5):2065-75.
Score: 0.031